# Codagenix Inc.

Canonical: https://abierto.us/vendors/codagenix-inc-temnl437k2f1

- UEI: TEMNL437K2F1
- CAGE: 5D8K5
- Location: Farmingdale, NY
- Awards in window: 1 (6 transactions), $0 obligated, February 8, 2024 to March 11, 2026

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, $0

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $0

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75A50123C00048 (definitive contract): $0, Barda - Aspr / Daappo / Barda DCMA. Conduct a Phase 2B Efficacy Study as Prescribed in AOI15 with Coviliv a Proprietary Live Attenuated Virus Covid-19 Vaccine.. https://www.usaspending.gov/award/CONT_AWD_75A50123C00048_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/codagenix-inc-temnl437k2f1.